Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Liver NeoplasmsAdenomaCarcinomaLiver Abscess
Interventions
DRUG

Gadoxetic Acid Disodium (Eovist, BAY86-4873)

Participants have received Primovist/Eovist for liver Magnetic Resonance Imaging (MRI) as part of their routine care at participating institutions and additional diagnostic information are identified retrospectively from institution records

Trial Locations (9)

10032

New York

17033

Hershey

27710

Durham

45229

Cinncinati

94304

Palo Alto

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY